These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20007697)

  • 1. Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.
    Tee AEL; Marshall GM; Liu PY; Xu N; Haber M; Norris MD; Iismaa SE; Liu T
    J Biol Chem; 2010 Feb; 285(6):3561-3567. PubMed ID: 20007697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
    Liu T; Tee AE; Porro A; Smith SA; Dwarte T; Liu PY; Iraci N; Sekyere E; Haber M; Norris MD; Diolaiti D; Della Valle G; Perini G; Marshall GM
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18682-7. PubMed ID: 18003922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
    Algarni AS; Hargreaves AJ; Dickenson JM
    Eur J Pharmacol; 2018 Feb; 820():113-129. PubMed ID: 29242118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the anticancer effect of the histone deacetylase inhibitor by activating transglutaminase.
    Ling D; Marshall GM; Liu PY; Xu N; Nelson CA; Iismaa SE; Liu T
    Eur J Cancer; 2012 Nov; 48(17):3278-87. PubMed ID: 22459762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Dependent Expression of TG2 Isoforms in Neuroblastoma Cells as Consequence of Different MYCN Amplification Status.
    Currò M; Ferlazzo N; Giunta ML; Montalto AS; Russo T; Arena S; Impellizzeri P; Caccamo D; Romeo C; Ientile R
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
    Kerr C; Szmacinski H; Fisher ML; Nance B; Lakowicz JR; Akbar A; Keillor JW; Lok Wong T; Godoy-Ruiz R; Toth EA; Weber DJ; Eckert RL
    Oncogene; 2017 May; 36(21):2981-2990. PubMed ID: 27941875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
    Johnson KA; Terkeltaub RA
    J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of transglutaminase 2 in PAC
    Algarni AS; Hargreaves AJ; Dickenson JM
    Biochem Pharmacol; 2017 Mar; 128():55-73. PubMed ID: 28065858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive Binding of Magnesium to Calcium Binding Sites Reciprocally Regulates Transamidase and GTP Hydrolysis Activity of Transglutaminase 2.
    Jeong EM; Lee KB; Kim GE; Kim CM; Lee JH; Kim HJ; Shin JW; Kwon MA; Park HH; Kim IG
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
    Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K
    Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
    Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
    Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
    Condello S; Cao L; Matei D
    FASEB J; 2013 Aug; 27(8):3100-12. PubMed ID: 23640056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.
    Tanaka K; Yokosaki Y; Higashikawa F; Saito Y; Eboshida A; Ochi M
    Matrix Biol; 2007 Jul; 26(6):409-18. PubMed ID: 17490870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.
    Begg GE; Holman SR; Stokes PH; Matthews JM; Graham RM; Iismaa SE
    J Biol Chem; 2006 May; 281(18):12603-9. PubMed ID: 16522628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells.
    Tucholski J; Lesort M; Johnson GV
    Neuroscience; 2001; 102(2):481-91. PubMed ID: 11166134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes.
    Valentijn LJ; Koppen A; van Asperen R; Root HA; Haneveld F; Versteeg R
    Cancer Res; 2005 Apr; 65(8):3136-45. PubMed ID: 15833843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
    Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
    Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.
    Han AL; Kumar S; Fok JY; Tyagi AK; Mehta K
    Eur J Cancer; 2014 Jun; 50(9):1685-96. PubMed ID: 24656569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site.
    Jang TH; Lee DS; Choi K; Jeong EM; Kim IG; Kim YW; Chun JN; Jeon JH; Park HH
    PLoS One; 2014; 9(9):e107005. PubMed ID: 25192068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
    Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
    J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.